Arsenal Aquisition

Breaking Blue

We’re pleased to announce that on 11th August Cello Health Plc, acquisition of the parent company of Breaking Blue, by funds managed by Arsenal Capital Partners (“Arsenal”) was completed.  For the Breaking Blue team and our clients, it’s very much ‘business as usual’ but we hope that Arsenal’s expertise, extensive investment activity, industry-shaping senior advisors, and access to capital will really help to bring innovation to the fore for us.

A short PR release about the news at the link below: https://cellohealth.com/news/arsenal-capital-partners-completes-182-million-acquisition-of-cello-health/

The Breaking Blue team is very excited to be part of this new venture!

For further information you can contact the team at hello@breakingblueresearch.com or on +44 (0) 20 7627 7700.